Short Term Opioid Withdrawal Using Buprenorphine Findings and Strategies HD

This webinar is designed to instruct treatment providers on the administration of a unique, buprenorphine taper intervention for opioid dependent patients. Research conducted in both inpatient and outpatient settings by the NIDA Clinical Trials Network demonstrate that, in contrast with the clonidine treatment group, patients receiving buprenorphine provided more opioid-negative urine samples upon completion of the intervention. This training assumes some basic prior information about what buprenorphine is and how it is used. Presenter: Marvis Doster is the Director of Nursing and Residential Services at Heartview Foundation. Slides: http://bit.ly/14OU9O8